Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 51,634 shares at $14.27 ($737K) on 2019-05-14, disclosed to the SEC on 2019-05-17.
Open-market sale of $737k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.27 | 25,817 | $368K | 50.0% |
| 2 | $14.27 | 25,817 | $368K | 50.0% |
| Total | $14.27 avg | 51,634 | $737K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |